(Q36203266)

12 August 2017

1 reference

title

Intravenous bisphosphonate therapy for osteoporosis: where do we stand? (English)

1 reference

12 August 2017

0 references

Henry G Bone

1

1 reference

12 August 2017

Werner Schurr

series ordinal

2

1 reference

12 August 2017

publication date

1 March 2004

1 reference

Current osteoporosis reports

12 August 2017

published in

1 reference

12 August 2017

volume

2

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

24-30

1 reference

https://scigraph.springernature.com/pub.10.1007/s11914-004-0011-5

12 August 2017

exact match

0 references

cites work

Characterization of the early ultrastructural and biochemical events occurring in dichloromethane diphosphonate nephrotoxicity

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11914-004-0011-5

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

21 January 2018

1 reference

12 December 2020

Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents

1 reference

12 December 2020

Bisphosphonate mechanism of action

1 reference

12 December 2020

Bisphosphonates in children with bone diseases

1 reference

12 December 2020

Daily oral pamidronate in women and men with osteoporosis: a 3-year randomized placebo-controlled clinical trial with a 2-year open extension

1 reference

12 December 2020

Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study.

1 reference

12 December 2020

Pharmacokinetics of alendronate

1 reference

12 December 2020

Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate

1 reference

12 December 2020

Intravenous pamidronate in juvenile osteoporosis

1 reference

12 December 2020

Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Disorders associated with acute rapid and severe bone loss

1 reference

12 December 2020

Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study

1 reference

12 December 2020

Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group

1 reference

12 December 2020

Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis

1 reference

12 December 2020

[Treatment of post menopausal osteoporosis with intravenous pamidronate in patients with esophagogastric pathology]

1 reference

12 December 2020

Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis

1 reference

12 December 2020

Short-term, high-dose pamidronate-induced acute tubular necrosis: the postulated mechanisms of bisphosphonate nephrotoxicity

1 reference

12 December 2020

Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions

1 reference

12 December 2020

Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study

1 reference

12 December 2020

Current and future directions in medical therapy: hypercalcemia

1 reference

12 December 2020

Management of multiple myeloma

1 reference

12 December 2020

Two years' effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopause.

1 reference

12 December 2020

Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study.

1 reference

12 December 2020

Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

1 reference

12 December 2020

Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis

1 reference

12 December 2020

Severe transient osteoporosis of the hip during pregnancy. Successful treatment with intravenous biphosphonates

1 reference

12 December 2020

The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate

1 reference

12 December 2020

Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis

1 reference

12 December 2020

Bisphosphonates in the management of metastatic prostate cancer

1 reference

12 December 2020

Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation

1 reference

12 December 2020

Pamidronate treatment improves bone mineral density in children with Menkes disease

1 reference

12 December 2020

Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis

1 reference

12 December 2020

Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronate

1 reference

12 December 2020

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

1 reference

12 December 2020

Safety of pamidronate in patients with renal failure and hypercalcemia

1 reference

12 December 2020

Cyclical clodronate is effective in preventing postmenopausal bone loss: a comparative study with transcutaneous hormone replacement therapy

1 reference

12 December 2020

Review of ibandronate in the treatment of osteoporosis

1 reference

12 December 2020

Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation.

1 reference

12 December 2020

Toxic acute tubular necrosis following treatment with zoledronate (Zometa).

1 reference

12 December 2020

Efficacy of intravenous pamidronate in osteoporosis, mineralometric evaluation

1 reference

12 December 2020

The role of bisphosphonates in the management of metastatic prostate cancer.

1 reference

12 December 2020

Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone

1 reference

12 December 2020

Effect of cyclical intravenous clodronate therapy on bone mineral density and markers of bone turnover in patients receiving home parenteral nutrition

1 reference

12 December 2020

Cyclical pamidronate infusions in postmenopausal osteoporosis.

1 reference

12 December 2020

Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation

1 reference

12 December 2020

Novel approaches to the management of bone metastases

1 reference

12 December 2020

The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study

1 reference

12 December 2020

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

12 December 2020

Short-term intravenous bisphosphonates in prevention of postmenopausal bone loss

1 reference

12 December 2020

Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study

1 reference

12 December 2020

Intravenous pamidronate in the treatment of transient osteoporosis of the hip.

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women

1 reference

12 December 2020

Renal Failure with the Use of Zoledronic Acid

1 reference

12 December 2020

Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis

1 reference

12 December 2020

The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

10.1007/S11914-004-0011-5

Identifiers

DOI

1 reference

12 August 2017

1 reference